No Data
No Data
Brother Enterprises' Unit Gets Nod to Market Iopamidol in Europe
Brother Enterprises Holding's (SHE:002562) unit, Jiangxi Brother Pharmaceutical, obtained the suitability certificate suitability from the European Directorate for the Quality of Medicines & HealthCar
Brother Technology (002562.SZ): Does not involve chemical synthesis of polyether ether ketone
Gelonghui, May 20 | Brother Technology (002562.SZ) said on the investor interactive platform that the company is not involved in the chemical synthesis of polyether ether ketone. Polyether ether ketone is a key application area for hydroquinone, and the company is still in the promotion stage.
Express News | Brother Technology: Wholly-owned subsidiary obtains CEP certificate for APIs
Express News | Brother Technology: Terminate construction project with an annual output of 30,000 tons of natural flavors
Brother Technology (002562.SZ): Net loss of 25.2 million yuan in the first quarter turned into a year-on-year loss
Gelonghui, April 29 | Brother Technology (002562.SZ) released its first quarter report. Operating revenue was 800 million yuan, up 21.1% year on year, net loss of 25.2 million yuan, turning loss year on year. After deducting non-net loss of 257.975 million yuan, basic earnings per share -0.0237 yuan.
Brother Technology (002562.SZ) issued a forecast loss. The net loss for the first quarter is expected to be 20 million yuan to 26 million yuan, changing from profit to loss over the previous year
Brother Technology (002562.SZ) released a performance forecast for the first quarter of 2024, which is expected to be owned by a listed company...
No Data